TechnipFMC Reports Strong Q4 & Full-Year 2025 Results, Raises 2026 Subsea Guidance, and Announces Major New Orders

summarizeSummary

TechnipFMC reported strong Q4 and full-year 2025 financial results, raised its 2026 Subsea guidance, secured significant new orders, and returned over $1 billion to shareholders for the year.

check_boxKey Events

• Strong Q4 and Full-Year 2025 Financial Performance

  Fourth-quarter 2025 revenue increased 6.3% year-over-year to $2.52 billion, with adjusted EBITDA up 25.5% to $440.5 million. For the full year, revenue grew 9.4% to $9.93 billion, and adjusted EBITDA surged 35% to $1.82 billion.

• Increased 2026 Subsea Guidance

  The company raised its full-year 2026 guidance for Subsea revenue to a range of $9.2 - $9.6 billion (from $9.1 - $9.5 billion) and increased the Subsea adjusted EBITDA margin guidance to 21 - 22% (from 20.5 - 22%).

• Significant New Subsea Orders and Backlog Growth

  Q4 Subsea inbound orders reached $2.3 billion, contributing to $10.1 billion for the full year. This included a 'Large' iEPCI™ contract from bp for the Tiber project, valued between $600 million and $800 million. Total company backlog grew 15.3% year-over-year to $16.57 billion.

• Substantial Shareholder Distributions

  TechnipFMC distributed $188.3 million to shareholders in Q4 2025, comprising $168.1 million in share repurchases and $20.2 million in dividends. Total shareholder distributions for the full year 2025 exceeded $1 billion.

auto_awesomeAnalysis

TechnipFMC plc delivered robust financial results for both the fourth quarter and full year 2025, exceeding prior year performance across key metrics. The company demonstrated strong operational momentum, particularly in its Subsea segment, which saw significant inbound orders and an increase in backlog. The decision to raise 2026 guidance for Subsea revenue and adjusted EBITDA margin signals management's confidence in continued growth and improved profitability. Furthermore, substantial shareholder distributions underscore a commitment to returning capital. These positive developments, coupled with the announcement of a large iEPCI™ contract, reinforce a favorable outlook for the company, especially as the stock trades near its 52-week high.